Optonol · raw details

Miniature Surgical Implants for Glaucoma Patients · Neve Ilan · Founded 1996

acquired Acquired ← back to profile

Highlights

1 patent

About

Miniature Surgical Implants for Glaucoma Patients

Optonol's flagship product, Ex-Press, is a miniature surgical implant used to lower intra-ocular pressure in patients with glaucoma. Optonol was founded as a spin-off of Jerusalem-based stent developer Medinol Ltd. Optonol was acquired by Alcon in December 2009. A year later, Alcon was acquired by Novartis.

Identity

NameOptonol
Slugoptonol
Type / kindstartup
Crunchbase IDoptonol
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKThkIcKDA

Status

Statusacquired
Status reasonAcquired by Alcon on Dec, 2009
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtJerusalem District
HQ cityNeve Ilan
HQ addressNeve Ilan, Israel

Web & social

Websitehttp://optonol.com
LinkedInhttps://www.linkedin.com/company/146920

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
imagingmedical-devicesglaucoma

Funding

Total raised$30.0M
Current stageAcquired

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}